PALI Live signals | Maximize Profits with Getagraph.com

BUY 135020 min ago

@ $0.419

Issued: 13 Feb 2024 @ 10:41

Return: 1 442.13%

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 16:00):

Stats
Today's Volume	29 435.00
Average Volume	1.16M
Market Cap	6.06M
EPS	$0 ( 2024-05-13 )
Next earnings date	( $-4.80 ) 2024-06-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.240
ATR14	$0.110 (1.71%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-07	Fischbein Margery B.	Sell	1 000	Common Stock Purchase Option
2024-05-06	Jones Mitchell Lawrence	Sell	304	Restricted Stock Units
2024-05-06	Jones Mitchell Lawrence	Sell	156	Restricted Stock Units
2024-05-06	Jones Mitchell Lawrence	Buy	156	Common Stock, par value $0.01
2024-05-06	Jones Mitchell Lawrence	Sell	47	Common Stock, par value $0.01

INSIDER POWER
29.34
Last 100 transactions
Buy: 488 044 \| Sell: 278 181

Volume Correlation

Long: -0.26 (neutral)

Short: 0.90 (strong)

Signal:(57.455) Same movement expected

Palisade Bio, Inc. Correlation

10 Most Positive Correlations
LSAQ	0.863
ESCA	0.853
RVLP	0.85
NVTSW	0.847
CYXT	0.846
DSWL	0.841
EXTR	0.84
GOODM	0.839
CTHR	0.838
UTMD	0.834

10 Most Negative Correlations
MSVB	-0.851
ARQT	-0.85
TRHC	-0.849
FEM	-0.845
MOR	-0.843
CVLT	-0.842
CRBP	-0.839
THRX	-0.838
ALXN	-0.833
JSPR	-0.833

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Palisade Bio, Inc. Correlation - Currency/Commodity

-0.01
( neutral )

0.03
( neutral )

0.00
( neutral )

0.28
( neutral )

0.46
( neutral )

0.01
( neutral )

Palisade Bio, Inc. Financials

Annual	2023
Revenue:	$250 000
Gross Profit:	$246 000 (98.40 %)
EPS:	$-27.01

FY	2023
Revenue:	$250 000
Gross Profit:	$246 000 (98.40 %)
EPS:	$-27.01

FY	2022
Revenue:	$0
Gross Profit:	$-167 000 (0.00 %)
EPS:	$-14.54

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-109.92

Financial Reports:

No articles found.

Palisade Bio, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.